Skin-F ® 22
In 1-mL syringe, contains 22 mg/ml cross-linked sodium hyaluronate in sterile buffered water with added glycine and L-proline.
The amino acids glycine and L-proline act to stabilize the hydrogel both chemically and mechanically, providing greater stability and optimal effectiveness of the product. Glycine helps maintain the stability of the product at low temperatures, while L-proline acts as a free radical scavenger, protecting hyaluronic acid from oxidation and improving its viscosity and stability under various conditions.
• The product being medium cohesive is particularly indicated for the
correction of lips and fine wrinkles.
INJECTION TECHNIQUE:
• retrograde sliding technique
• superficial layer of the dermis
TREATMENT AREA:
• crow's feet,
• nasogenetic wrinkles,
• barcode,
• lip contour,
• thin lips,
• marionettes.
CONTRAINDICATIONS:
SKIN F 22 is contraindicated in the following cases:
• In association with chemical peels, laser treatments or dermabrasions.
• In patients with a tendency to develop hypertrophic scars.
• In patients with infections and inflammations (acne, herpes, dermatitis,
etc.) in situ or near the area subject to treatment.
• Patients treated with anticoagulants.
• Patients undergoing radiotherapy or ultrasound therapy in the area to
be treated.
• Patients with hypersensitivity to hyaluronic acid.
• Patients with untreated epilepsy.
• Patients with known hypersensitivity or allergy to any of the
components.
• Patients with a skin condition or alteration of any kind.
• In pregnant or lactating women or children.
• The use of the product must be absolutely excluded in areas where
there are mammary, tendon, bone and muscle implants.
• a declared auto-immune disease
• Patients with a history of streptococcal disease, such as relapsing angina
or acute rheumatism.
SPECIAL PRECAUTIONS FOR STORAGE:
• Store the product at a temperature between 2 ° C and 30 ° C.
• Do not expose to sunlight.
• Do not freeze, do not heat.